StonvexLoading…
StonvexStonvexStonvexCore line items from NVO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | DKK 309.06B | DKK 290.40B | DKK 232.26B | DKK 176.95B |
Operating Income | DKK 127.66B | DKK 128.34B | DKK 102.57B | DKK 74.81B |
Net Income | DKK 102.43B | DKK 100.99B | DKK 83.68B | DKK 55.52B |
EPS (Diluted) | DKK 23.03 | DKK 22.63 | DKK 18.62 | DKK 12.22 |
Total Assets | DKK 542.90B | DKK 465.63B | DKK 314.49B | DKK 241.26B |
Total Liabilities | DKK 348.86B | DKK 322.14B | DKK 207.93B | DKK 157.77B |
Cash & Equivalents | DKK 26.46B | DKK 15.65B | DKK 14.39B | DKK 12.65B |
Free Cash Flow OCF − CapEx | DKK 58.96B | DKK 73.80B | DKK 83.10B | DKK 66.74B |
Shares Outstanding | 4.44B | 4.44B | 4.46B | 4.50B |